A Randomized, Open-label, Dose-ranging Study of Oral Delayed Release Prednisone in Patients With Untreated Polymyalgia Rheumatic (PMR)
Phase of Trial: Phase II
Latest Information Update: 06 May 2017
At a glance
- Drugs Prednisone (Primary)
- Indications Polymyalgia rheumatica
- Focus Therapeutic Use
- 01 May 2017 The phase has been from Phase 4 to phase 2.
- 01 May 2017 Status changed from recruiting to discontinued.
- 15 Mar 2016 New trial record